"The U.S. Food and Drug Administration recently approved Oralair to treat allergic rhinitis (hay fever) with or without conjunctivitis (eye inflammation) that is induced by certain grass pollens in people ages 10 through 65 years. Oralair is the f"...
DOSAGE AND ADMINISTRATION
Adults and pediatric patients over 12 years - 2 teaspoonsful (10 mL) every 4 hours, not to exceed 8 teaspoonsful in 24 hours. Pediatric patients 6 to 12 years - 1 teaspoonful (5 mL) every 4 hours, not to exceed 4 teaspoonsful in 24 hours. Pediatric patients under 6 years - use only as directed by a physician.
Bottles of 16 fl. oz. (473 mL) NDC 58177-877-07
Bottles of 32 fl. oz. (946 mL) NDC 58177-877-12
KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. IN CASE OF ACCIDENTAL OVERDOSE, SEEK PROFESSIONAL ASSISTANCE OR CONTACT A POISON CONTROL CENTER IMMEDIATELY.
Store at controlled room temperature, 59°-86°F (15°-30°C)
Dispense in tight, child resistant, light-resistant containers as defined by the USP/NF.
Manufactured by: KV Pharmaceutical Co. for ETHEX Corporation St. Louis, MO 63043-2413. Rev. 10/98.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 4/9/2009
Additional Histinex HC Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Allergies & Asthma
Improve treatments & prevent attacks.